Holdings of Invesco Biotechnology & Genome ETF
Invesco Exchange-Traded Fund Trust · 30 declared positions · as of Apr 30, 2026
Original filing · Net assets 247.4M $ · Ten largest lines: 47.2 % of the equity sleeve
Sector breakdown
- Health care 18.9 %
- Unattributed 81.1 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 100.0 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 30 | 247.5M $ | 100.00 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| United Therapeutics Corp | 27,212 | 15.5M $ | 6.28 % |
| Illumina Inc | 104,832 | 13.3M $ | 5.37 % |
| Biogen Inc | 66,025 | 12.5M $ | 5.05 % |
| Incyte Corp | 127,499 | 12.1M $ | 4.91 % |
| Alnylam Pharmaceuticals Inc | 38,706 | 12M $ | 4.84 % |
| Regeneron Pharmaceuticals, Inc. | 16,684 | 11.8M $ | 4.77 % |
| Amgen Inc | 33,651 | 11.7M $ | 4.71 % |
| Gilead Sciences Inc | 87,264 | 11.4M $ | 4.62 % |
| BioCryst Pharmaceuticals Inc | 923,458 | 8.5M $ | 3.42 % |
| Catalyst Pharmaceuticals Inc | 290,513 | 8.2M $ | 3.30 % |
| Arrowhead Pharmaceuticals Inc | 110,374 | 8.1M $ | 3.28 % |
| Protagonist Therapeutics Inc | 80,415 | 8M $ | 3.22 % |
| TG Therapeutics Inc | 230,335 | 7.8M $ | 3.15 % |
| Royalty Pharma PLC | 154,791 | 7.8M $ | 3.13 % |
| CareDx Inc | 365,065 | 7.6M $ | 3.07 % |
| Neurocrine Biosciences Inc | 53,660 | 7.1M $ | 2.86 % |
| Exelixis Inc | 155,682 | 6.9M $ | 2.80 % |
| Bio-Techne Corp | 122,004 | 6.7M $ | 2.73 % |
| PTC Therapeutics Inc | 101,877 | 6.6M $ | 2.68 % |
| Veracyte Inc | 196,903 | 6.5M $ | 2.62 % |
| ACADIA Pharmaceuticals Inc | 285,787 | 6.4M $ | 2.59 % |
| Vericel Corp | 183,726 | 6.4M $ | 2.58 % |
| Halozyme Therapeutics Inc | 99,880 | 6.4M $ | 2.57 % |
| Repligen Corp | 52,183 | 6.2M $ | 2.50 % |
| Theravance Biopharma Inc | 368,704 | 6.2M $ | 2.50 % |
| Ionis Pharmaceuticals Inc | 82,240 | 6.1M $ | 2.49 % |
| BioMarin Pharmaceutical Inc | 112,225 | 6.1M $ | 2.45 % |
| Collegium Pharmaceutical Inc | 155,578 | 5.2M $ | 2.12 % |
| QIAGEN NV | 144,898 | 5M $ | 2.03 % |
| MannKind Corp | 1,268,504 | 3.6M $ | 1.45 % |